These results are consistent with those observed in chronic lymphocytic leukemia, another B‐cell malignancy, where responses were independent of 17p deletion, TP53 mutation, and TP53 function.30 The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.